Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Oct;22(7):834-838.
doi: 10.1111/ner.12873. Epub 2018 Oct 16.

A Novel Approach to Avoid Baclofen Withdrawal When Faced With Infected Baclofen Pumps

Roy S Hwang  1 , Vishad Sukul  1   2 , Claire Collison  1 , Julia Prusik  1   2 , Julie G Pilitsis  1   2
Affiliations
Case Reports

A Novel Approach to Avoid Baclofen Withdrawal When Faced With Infected Baclofen Pumps

Roy S Hwang et al. Neuromodulation. 2019 Oct.

Abstract

Background: Intrathecal (IT) Baclofen is beneficial for spasticity, but if pumps become infected necessitating removal, baclofen withdrawal is difficult to manage and life-threatening. Furthermore there is no consistency between dosing and severity of withdrawal. Case reports detail full baclofen withdrawal at dosages of 260 μg/day.

Objective: To demonstrate that in patients on stable IT baclofen for prolonged periods, externalizing a patient's original IT pump is a safe, effective way to wean IT doses.

Methods: Here, we describe a technique of continuing IT baclofen when urgent pump removal is needed. Specifically, we remove the infected pump. Then using a new or existing lumbar drain based on extent of infection, we reconnect the pump after cleaning with betadine and administer therapy externally during IT weaning.

Results: Hundred forty seven baclofen pumps were implanted or replaced within four years. Infections occurred in seven patients. We utilized this technique in five of seven patients. Mean IT dose at time of explant was 400.5 ± 285.3 μg/day. We titrated the dose by 20-50% per day based on clinical response over a mean of 6.2 ± 1.3 days. The catheter was removed at bedside once weaning was complete. No patients had any signs of withdrawal, excluding minimal spasticity increases while optimizing oral treatment.

Conclusion: Here, we show preliminary evidence that an externalized IT pump is an effective means of weaning IT baclofen when infection of the pump occurs. This treatment strategy warrants further investigation, but appears to be a safe and effective.

Conflict of interest: Dr. Pilitsis is a consultant for Medtronic, Boston Scientific, Nevro, Jazz Pharmaceuticals, Neurobridge Therapeutics, and Abbott and receives grant support from Medtronic, Boston Scientific, Abbott, Nevro, Jazz Pharmaceuticals, GE Global Research and NIH 1R01CA166379. She is medical advisor for Centauri and Karuna and has stock equity. Dr. Sukul receives consultant fees from Medtronic. Julia Prusik receives grant support from Jazz Pharmaceuticals.

Keywords: Baclofen withdrawal; externalized; intrathecal; lumbar catheter; pump infection; spasticity.

PubMed Disclaimer

References

REFERENCES

    1. Albright A, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991;265:1418-1425.
    1. Coffey R, Ridgely P. Abrupt intrathecal baclofen withdrawal: management of potentially life-threatening sequelae. Neuromodulation 2001;4:142-146.
    1. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77:236-240.
    1. Creamer M, Cloud G, Kossmehl P et al. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). J Neurol Neurosurg Psychiatry 2018;89:11-650.
    1. Health Quality Ontario. Intrathecal baclofen pump for spasticity: an evidence-based analysis. Ont Health Technol Assess Ser 2005;5:1-93.

Publication types

MeSH terms